Bird flu is a dangerous virus that has been making many headlines in recent months. A pandemic is not inevitable, scientists say. But the outbreak has passed worrisome milestones in recent weeks. People have become increasingly aware of how dangerous viruses can be, including Bird flu.
This puts the spotlight on emerging tiny biotech firm NanoViricides, Inc. (NYSE: NNVC), a company that is revolutionizing antiviral drug where viruses are unlikely to escape!
NNVC's broad-spectrum antiviral drug candidate NV-387 is the best weapon to fight a potential bird flu pandemic because the mercurial H5N1 Influenza A virus would not be able to escape the drug. This could be groundbreaking in what may become another pandemic.
A vaccine against a rapidly changing virus is a game of chasing a rapidly moving target, as we have all learned from the experience during the COVID-19 pandemic. It is thus clear that a drug that the virus cannot escape is the only appropriate tool to fight a potential pandemic and NNVC has developed such a drug! NV-387 is a broad-spectrum antiviral that mimics the very host-side features that the virus continues to require no matter how much it changes in the field. It is highly unlikely that a susceptible virus would escape such a drug.
Notably NV-387 has demonstrated substantially superior activity to existing influenza drugs in a lethal lung infection animal study. NNVC recently announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum antiviral drug NV-387 further into the regulatory pipeline.
The Company has previously stated that it is working towards a Phase II clinical trial to evaluate the effectiveness of NV-387 for the treatment of MPox patients. MPox disease, caused by the human Mpox virus (hMPXV) has been causing a regional pandemic encompassing several countries in the African region. Hundreds of millions of dollars of taxpayer money have gone towards ineffective antiviral drugs that do NOT work against MPox/Smallpox!
Discover how NNVC's broad-spectrum antiviral drug NV-387 is poised to cause a revolution in treatment of viral diseases and could lead to tremendous shareholder value.
Company News from this Morning:
NanoViricides eyes role in US bird flu fight as USDA unveils $100M initiative
If you are reading this message, it's because you are using an older device. So, we want to ensure that you know a few things, including: Why you're receiving these emails How we treat your privacy How to manage your preferences How to access important pages Our commitment to you A bit of legal Hello, and thank you for taking the time to read this email. This message is part of an ongoing conversation between us, and I want to take a moment to ensure you have full transparency about why you received this message, how your information is handled, and what to expect from future emails. Why You're Receiving This Email You're receiving this email because at some point, you opted in to receive updates, news, or information on a specific topic we've previously discussed or shared. Whether it was through a subscription, a form submission, or another form of communication, your information was shared willingly, and we respect your decision to connect with us. If you're wondering about the nature of our correspondence, rest assured that we aim to keep all emails relevant, timely, and free from unnecessary clutter. This includes respecting your inbox and refraining from sending irrelevant messages. Your Privacy is Important We value your trust and take your privacy very seriously. The information you provide is securely stored and never shared, sold, or used outside the purpose for which you provided it. If you ever want to review how we handle your data, feel free to contact us directly. Transparency is our priority, and we're happy to address any questions you might have. You are always in control of the information you share. If you feel that any part of your subscription or interaction needs clarification, let us know. We're here to provide accurate answers and ensure your satisfaction. How to Unsubscribe or Manage Your Preferences We understand that everyone's inbox is different. If you ever find our emails no longer relevant, there's no hard feelings. You can easily manage your email preferences or unsubscribe using the link provided below. By clicking the unsubscribe link, you'll be taken to a page where you can either adjust your communication preferences (such as receiving fewer emails or only on specific topics) or completely remove yourself from our list. The process is straightforward, and any changes will take effect promptly. We don't use tricks or gimmicks to keep you subscribed. Our priority is to ensure that our emails add value to your day, and if they don't, we respect your decision to part ways. Accessibility and Communication If you have any trouble accessing the unsubscribe page, managing preferences, or understanding why you're receiving this email, you can reach out directly to our support team at [support@example.com]. We aim to provide a response within a reasonable time frame and address your concerns effectively. Our communication is designed to be as inclusive as possible, but we know there's always room for improvement. If you have any feedback on how we can make our emails more accessible or relevant, please don't hesitate to share. A Commitment to Non-Intrusive Emails We aim to create a non-intrusive communication experience. This means we won't overwhelm your inbox with excessive messages, and we work hard to ensure our content remains clear and concise. The purpose of this email is to stay connected with you and provide updates or information that we believe is meaningful. If we ever fail to meet these standards, we encourage you to let us know. Feedback, whether positive or constructive, is always appreciated. Your thoughts help us understand how we can do better and improve our communication approach. While we cannot guarantee every suggestion will be implemented, we will take the time to carefully review and consider your input. Contact Information If you'd like to get in touch with us outside of managing your preferences, here's how you can reach us: Email: Phone: [123-456-7890] (Available Monday through Friday, 9 AM - 5 PM MST) Mailing Address: We strive to ensure all communication channels are open and readily available to you. Whether it's a question, comment, or concern, our team is ready to assist. Legal Information We comply with all applicable laws and regulations regarding email communication. This includes adhering to anti-spam laws and maintaining the highest standards for consent-based communication. Your trust matters, and we work diligently to ensure every email you receive meets these requirements. If you need further clarification on our compliance policies or legal obligations, please feel free to ask. Transparency and accountability are central to our communication strategy, and we're happy to provide additional details if needed. A Final Note Emails are one of the many ways we stay connected, but we understand they aren't perfect for everyone. If there's another way you'd prefer to communicate or stay updated, let us know. Whether it's through social media, a direct call, or another channel, we're open to finding the most effective way to share information with you. We want to emphasize that our goal is never to disrupt or clutter your inbox. Every email sent is intended to provide value, and we genuinely appreciate your time and attention. Thank you for allowing us to stay in touch with you. This footer was designed to ensure transparency, provide essential information, and give you full control over your communication preferences. We hope it meets your expectations, but if there's anything you'd like to see improved, we're always here to listen.
No comments:
Post a Comment